ES2376557T3 - Compuestos basados en péptidos. - Google Patents

Compuestos basados en péptidos. Download PDF

Info

Publication number
ES2376557T3
ES2376557T3 ES05752383T ES05752383T ES2376557T3 ES 2376557 T3 ES2376557 T3 ES 2376557T3 ES 05752383 T ES05752383 T ES 05752383T ES 05752383 T ES05752383 T ES 05752383T ES 2376557 T3 ES2376557 T3 ES 2376557T3
Authority
ES
Spain
Prior art keywords
compound
amino acid
peptide
cyanine dye
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES05752383T
Other languages
English (en)
Spanish (es)
Inventor
Alan Cuthbertson
Robert James Nairne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
GE Healthcare AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GE Healthcare AS filed Critical GE Healthcare AS
Application granted granted Critical
Publication of ES2376557T3 publication Critical patent/ES2376557T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70546—Integrin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/12—Cyclic peptides with only normal peptide bonds in the ring
    • C07K5/126—Tetrapeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G01N33/532—Production of labelled immunochemicals
    • G01N33/533—Production of labelled immunochemicals with fluorescent label

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES05752383T 2004-06-16 2005-06-15 Compuestos basados en péptidos. Expired - Lifetime ES2376557T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20042523 2004-06-16
NO20042523 2004-06-16
PCT/NO2005/000210 WO2005123768A1 (en) 2004-06-16 2005-06-15 Peptide-based compounds

Publications (1)

Publication Number Publication Date
ES2376557T3 true ES2376557T3 (es) 2012-03-14

Family

ID=34979156

Family Applications (1)

Application Number Title Priority Date Filing Date
ES05752383T Expired - Lifetime ES2376557T3 (es) 2004-06-16 2005-06-15 Compuestos basados en péptidos.

Country Status (10)

Country Link
US (1) US7897142B2 (enExample)
EP (1) EP1765863B1 (enExample)
JP (1) JP5280683B2 (enExample)
CN (2) CN101001870A (enExample)
AT (1) ATE538135T1 (enExample)
BR (1) BRPI0512209A (enExample)
ES (1) ES2376557T3 (enExample)
PL (1) PL1765863T3 (enExample)
RU (1) RU2393167C2 (enExample)
WO (1) WO2005123768A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL159310A0 (en) * 2001-07-10 2004-06-01 Amersham Health As Peptide-based compounds
DE602005025911D1 (de) * 2004-11-22 2011-02-24 Ge Healthcare As Kontrastmittel für eine extrazelluläre matrix
ITMI20050328A1 (it) 2005-03-03 2006-09-04 Univ Degli Studi Milano Composti peptidomimetrici e preparazione di derivati biologicamente attivi
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
WO2009114776A2 (en) * 2008-03-14 2009-09-17 Visen Medical, Inc. Integrin targeting agents and methods of using same
US20100291706A1 (en) * 2009-05-15 2010-11-18 Millipore Corporation Dye conjugates and methods of use
ES2398042T3 (es) * 2009-10-21 2013-03-13 Cyanagen Srl Kit y procedimiento para el marcaje de biomoléculas
EP2588541A1 (en) 2010-06-29 2013-05-08 GE Healthcare AS Dye compositions and dye syntheses
GB201010878D0 (en) 2010-06-29 2010-08-11 Ge Healthcare As Dye compositiion and dye syntheses
CN104470546B (zh) * 2012-07-20 2018-02-27 佳能株式会社 化合物和含有所述化合物的光声成像造影剂
US20150258217A1 (en) * 2012-10-04 2015-09-17 The General Hospital Corporation Methods of Synthesizing and Using Peg-Like Fluorochromes
WO2015059368A1 (fr) * 2013-09-02 2015-04-30 L'oreal Procede de coloration des fibres keratiniques a partir de colorants cationiques styryles disulfures, et composition comprenant lesdits colorants
CN107022350A (zh) * 2017-04-20 2017-08-08 深圳大学 一种荧光造影材料及其制备方法与应用
CN107739528A (zh) * 2017-09-30 2018-02-27 武汉工程大学 一种五肽改性菁染料化合物及其制备方法和应用
IL287989B2 (en) 2019-05-13 2025-07-01 Bracco Imaging Spa Modified cyanine dyes and their conjugates
CN115298194A (zh) * 2020-03-30 2022-11-04 一丸自然美健有限公司 Vipr2拮抗肽
US12180401B2 (en) 2021-04-07 2024-12-31 Becton, Dickinson And Company Water-soluble fluorescent polymeric dyes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4445065A1 (de) * 1994-12-07 1996-06-13 Diagnostikforschung Inst Verfahren zur In-vivo-Diagnostik mittels NIR-Strahlung
DE19917713A1 (de) * 1999-04-09 2000-10-19 Diagnostikforschung Inst Kurzkettige Peptid-Farbstoffkonjugate als Konstrastmittel für die optische Diagnostik
AU2001250683B2 (en) * 2000-04-12 2006-06-29 Ge Healthcare As Peptide-based compounds
IL159310A0 (en) * 2001-07-10 2004-06-01 Amersham Health As Peptide-based compounds
NO20033115D0 (no) 2003-07-08 2003-07-08 Amersham Health As Peptid-baserte forbindelser

Also Published As

Publication number Publication date
PL1765863T3 (pl) 2012-05-31
RU2006144279A (ru) 2008-07-27
US20080095715A1 (en) 2008-04-24
EP1765863A1 (en) 2007-03-28
RU2393167C2 (ru) 2010-06-27
BRPI0512209A (pt) 2008-02-19
US7897142B2 (en) 2011-03-01
CN101001870A (zh) 2007-07-18
JP2008504237A (ja) 2008-02-14
JP5280683B2 (ja) 2013-09-04
ATE538135T1 (de) 2012-01-15
EP1765863B1 (en) 2011-12-21
WO2005123768A1 (en) 2005-12-29
CN1968963A (zh) 2007-05-23

Similar Documents

Publication Publication Date Title
ES2376557T3 (es) Compuestos basados en péptidos.
ES2396368T3 (es) Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
ES2763237T3 (es) Conjugados de péptidos de RGD y fotosensibilizantes de (bacterio)clorofila y sus usos
CA2452923C (en) Peptide-based compounds for targeting integrin receptors
CN102264756B (zh) 含rgd的拟肽和其用途
ES2385066T3 (es) Péptidos de unión a HGF marcados para la formación de imágenes
ES2244607T3 (es) Derivados peptidicos de union a integrina.
Pilkington-Miksa et al. Design, synthesis, and biological evaluation of novel cRGD–paclitaxel conjugates for integrin-assisted drug delivery
BR112017008575B1 (pt) Ligantes de peptídeos bicíclicos específicos a mt1-mmp, conjugado de fármaco, processo para preparação de um conjugado de fármaco e composição farmacêutica
US20100015058A1 (en) Radiolabeled bbn-rgd heterodimers for cancer targeting
CN103044522B (zh) 与整合素αvβ3受体具有高亲和力的多肽
AU2018363807A1 (en) A double-labeled probe for molecular imaging and use thereof
ES2361670T3 (es) Péptidos marcados con fluoresceína.
ES2358745T3 (es) Agentes de contraste para señalar matriz extracelular.
CN106188270A (zh) Rhamm结合肽
AU2005254915B2 (en) Peptide-based compounds